OBJECTIVES: To investigate the role of blood rheology changes in the occurrence of glomerular proteinuria in obese patients with central fat distribution. SUBJECTS: Fifty-nine obese out-patients (31 with central and 28 with peripheral body fat distribution) and 24 healthy subjects. MEASUREMENTS: Blood and plasma viscosity (Rotational viscometer CV100 HAAKE), erythrocyte deformability (whole-blood ®ltration time), ®brinogen (nephelometry), urinary excretion rates of albumin, IgG, transferrin and IgA (nephelometry). RESULTS: Higher blood viscosity (at low and high shear-rates), plasma viscosity, ®brinogen, erythrocyte aggregability and lower erythrocyte deformability were found in patients with central obesity than in patients with peripheral obesity (P`0.01) and in healthy subjects (P`0.001). Furthermore an increased urinary excretion rate of albumin (P`0.001), IgG (P`0.001), transferrin (P`0.01) and IgA (P`0.05) was found in patients with central obesity than in the other two groups. Blood hyperviscosity (at shear-rate 1 s 71 and 1/200 ratio) signi®cantly correlated with the amount of urinary excretion of proteins independently of the other clinical and metabolic variables. CONCLUSIONS: The data demonstrated haemorheologic disorders related to pathologic proteinuria in patients with central obesity. The interaction between these two components may increase the risk of widespread cardiovascular disease.
Introduction
Cardiovascular disorders characterize the clinical course of obesity inducing an increased prevalence of morbid and mortal sequelae. 1±9 The vascular damage can be linked to several risk factors including hypertension, hyperviscosity, metabolic changes and proteinuria. 10±19 Moreover, these abnormalities more frequently occur in central obesity compared to the peripheral type of the disease.
12±14,20±24 In particular, blood hyperviscosity, hyper®brinogenaemia and reduced red cell deformability can be associated with blood¯ow disturbances and atherogenesis, 25±27 while microalbuminuria may potentially re¯ect a widespread vascular disease and indicate a risk for cardiovascular and renal damage.
28±32
No data concerning the simultaneous evaluation of haemorheologic pattern and glomerular permeability to proteins in obesity are present in the literature. It is apparent from diabetes mellitus, that proteinuria and renal functional disorders might be haemorheologically dependent and associated with angiopathic alterations. 33±36 Moreover the suggested relationship between renal and rheological components in obesity might provide important pathophysiological factors associated with cardiovascular disease. In this context, the aim of the present work was to evaluate haemorheology together with renal haemodynamic function and urinary protein excretion rate in patients with central and peripheral obesity, and to consider this in relation to several metabolic characteristics of the patients studied.
Materials and methods

Subjects
The study concerned 59 obese out-patients and 24 age and sex-matched healthy subjects. Clinical and biochemical ®ndings of obese patients and control subjects are reported in Table 1 . All the subjects gave their informed consent to the study. Weight and height of healthy subjects and obese patients were determined in the fasting state without shoes and clothes. Obesity was de®ned on the basis of Body Mass Index (BMI) higher than 30.5 kg/m 2 for men and 27.3 kg/m 2 for women. 37 The ratio of waist to hip circumferences (WHR) was chosen as an index of body fat distribution. Anthropometric measurements were assessed to the nearest mm with a plastic tape, the subjects being in a standing position and breathing normally. Waist was determined at the smallest waist circumference, and the hip circumference measured at the level of the great trochanter. Central obesity was de®ned as occurring when WHR b 0.82 for women and b 0.92 for men. 37 Exclusion criteria for obese patients included severe hypertension, cardiovascular and renal diseases, smoking, diabetes mellitus, alcoholism, intercurrent illness and clinical symptoms of sleep apnea syndrome.
Glucose tolerance of both healthy subjects and obese patients was assessed by measuring blood glucose responsiveness to OGTT (75 g orally); serum insulin and glucagon were concomitantly determined.
Methods
Arterial blood pressure was evaluated twice in the supine position by using a standard mercury sphygmomanometer.
All the biochemical parameters were determined by an automatic procedure (DASIT, Autoanalyzer, Cornaredo, Milano, Italy). Venous haematocrit and mean corpuscular volume (MCV) were evaluated by an automatic cell counter (DASIT, Sysmex TOA F800 cell counter, Cornaredo, Milano, Italy). Serum insulin and glucagon were evaluated by double antibody RIA (DPC, Los Angeles, CA, USA).
Renal haemodynamic function was determined by measuring glomerular ®ltration rate (GFR) using a single intravenous injection of 2 mCi of 99 mTc-DTPA.
Urinary excretion rates of albumin, IgG, IgA, transferrin and a1-microglobulin were evaluated within 48 h from sampling. A 24 h urine collection in sterile cool containers was obtained for each patient and subject, afterwards urine samples were centrifuged at 250 g at 18 C and stored at 4 C until the assay. Urinary proteins were determined by an automatic nephelometric procedure (Behring Nephelometer Analyzer, Behringwerke AG, Marburg, Germany); urinary albumin, IgG, IgA and transferrin were expressed as dynamic excretion rate in mg/min, a1-microglobulin in mg/L. Plasma ®brinogen and ®bronectin were measured (sampling with sodium citrate 0.5:5 mL v:v) also by nephelometry. All the nephelometric evaluations were performed by using speci®c antiserum, calibrators and controls (Behringwerke AG, Marburg, Germany). Plasma non esteri®ed fatty acids (NEFA) were measured by a colorimetric micromethod. 40 Haemorheologic measurements were performed according to the guidelines of the International Committee for the standardization in haematology. 38 The venous blood was drawn from an antecubital vein without stasis and collected with speci®c tubes; tests were completed within 1 hour from venepuncture. Blood and plasma viscosity were measured on anticoagulated whole-blood and plasma (with K 2 EDTA) at 37 C (Thermostat HAAKE digital F3 Karlsrhue, Germany) with a rotational cone/plate (MooneyEwart's sensor M31), viscometer HAAKE (Rotovisco R20 CV 100 HAAKE, Karlsrhue, Germany), connected to a Rheocontroller RC 20 HAAKE and a computerized system ASEM-DESK 2010 (ASEM SpA, Buia, Italy). Haemorheologic data were analyzed by a speci®c rotational software HAAKE containing a regression analysis model, employed to connect data points of rheological measurements and to identify the¯ow curve of the sample (rheogram). Measurements, expressed in milliPascal 6 seconds (mPa Á s; 1 mPa Á s 1 centipoise) were made at shear-rates of 200 and 1 s 71 , for blood viscosity, and at shear-rate of 300 s 71 for plasma viscosity. The erythrocyte aggregability was derived from the ratio between the measurement of blood viscosity at shear rates of 1 and 200 s 71 (1/200 ratio). The erythrocyte deformability was measured by a ®ltration technique 39 with polycarbonate ®lters of diameter 5 m (Hema®l, Bio-Rad, Richmond, CA, USA). Filtration was carried out at 37 C on whole-blood anticoagulated with Na 2 -EDTA (pH 7.3, 0.2 mL/5 mL blood) ®ltered under a negative pressure of 20 cm water; results were expressed as the volume of whole-blood (mL) per minute.
Statistical analysis
Data are expressed as mean AE standard deviation (s.d.). Differences among the groups were evaluated by one-way ANOVA followed by Scheffe's F-test. Univariate correlation coef®cients (r) were used to evaluate the relationship between renal haemodynamic function and haemorheologic parameters. Multiple regression analysis was performed to assess the relation of independent variables (clinical, haemorheologic and metabolic parameters) with the urinary excretion rates of albumin, IgG, transferrin and IgA as the dependent variables. P`0.05 was accepted as the threshold of statistical signi®cance (two-tailed). All analyses were run with the SPSS/PC V3.0 statistical package. Table 1 summarizes the clinical, biochemical and haematological characteristics of healthy subjects and obese patients. All the three groups were comparable for sex, age and arterial blood pressure levels. Central and peripheral obese patients were also comparable for BMI, whereas WHR clearly differentiated the two groups of obese. No changes related to creatinine and blood urea were found in obese patients compared to the healthy subjects. Higher total (P`0.01) and LDL-cholesterol (P`0.001), triglyceride (P`0.001) and NEFA (P`0.001) and lower HDL-cholesterol (P`0.01) concentrations were demonstrated in central obese patients than in patients with peripheral body fat distribution. Table 2 summarizes blood glucose, serum insulin and glucagon concentrations before and after OGTT in healthy subjects and obese patients. Fasting blood glucose, insulin and glucagon were similar in healthy subjects and in patients with peripheral obesity. Moreover no changes between these two groups were observed with regard these parameters throughout OGTT. On the contrary higher blood glucose and insulin concentrations were demonstrated during OGTT in patients with central obesity than in the other two groups. Fasting insulin was also signi®-cantly increased in patients with central obesity (P`0.01), while only a slight, but not signi®cant, enhancement of fasting glucagon concentrations was demonstrated in the same group of patients. Glucagon responsiveness to OGTT was signi®cantly reduced (P`0.001) in patients with central obesity in comparison with healthy and peripheral obese subjects. (P`0.01), SR 1/200 ratio (P`0.01) and plasma viscosity (P`0.01) values were found in patients with central obesity than in patients with peripheral obesity or healthy subjects (P`0.001 for each parameter). Increased values of all the haemorheological parameters were also demonstrated in patients with peripheral obesity (P`0.01) compared to healthy subjects. Figure 2 shows the mean variations (s.d.) of plasma ®brinogen and erythrocyte deformability in healthy and obese subjects. Higher ®brinogen (P`0.01) and lower erythrocyte deformability values (P`0.001) were demonstrated in patients with central obesity than in those with peripheral obesity and in healthy subjects (P`0.001 for each parameter). Signi®cantly increased ®brinogen concentrations were also found in patients with peripheral obesity in comparison with healthy subjects.
Results
No differences concerning venous haematocrit and MCV were observed between obese patients and healthy subjects (Table 1) , while plasma ®bronectin concentrations were signi®cantly increased in patients with central obesity (31 AE 2.7 mg/dL) in comparison with peripheral obese (21 AE 3.2, P`0.01) and healthy subjects (22.3 AE 3.6 mg/dL, P`0.01). Figure 3 reports the mean variations (s.d.) of urinary excretion rate of proteins in healthy and , r 0.13 at SR 1/200 ratio), plasma viscosity (r 0.08) and erythrocyte deformability (r 70.16) were found in obese patients with central fat distribution. Table 3 summarizes multiple linear regression analysis among the urinary excretion rates of proteins (as dependent variables) and the clinical, haemorheological and metabolic parameters (as the independent variables) in patients with central obesity. In these patients, blood viscosity at low shear-rate (1 s 71 ) and erythrocyte aggregability (derived from blood viscosity at SR 1/200 ratio) signi®cantly correlated with the urinary excretion rates of albumin, IgG and IgA, whereas no correlation among the other clinical, haemorheological and metabolic parameters and the urinary excretion rate of proteins were demonstrated. In particular, arterial blood pressure, serum glucose, insulin, glucagon, cholesterol and triglycerides had no Central obesity, blood rheology and proteinuria SB Solerte et al in¯uence on the relationships observed when these factors were incorporated as independent variables. Finally no correlations were found among these parameters when healthy subjects and patients with peripheral obesity were considered (data not shown).
Discussion
In agreement with the existing knowledge, the present study con®rms the occurrence of haemorheological, renal and metabolic disorders in obese patients and in particular in those with central body fat distribution. 10±24 It is also evident that these changes may contribute to enhance the risk for cardiovascular complications, 1±9 reducing life expectancy in these patients. Although in line with these observations, the present work has several important novel aspects, regarding blood rheology, plasma proteins and glomerular permeability to proteins in obesity.
The most important rheological changes concerned patients with central obesity even if several disorders were also present in the patients with peripheral fat distribution. In addition to that already demonstrated for low shear rate blood viscosity 10±12,14±16 enhanced high shear rate blood viscosity was found in obese patients, particularly with central fat distribution. Increased blood viscosity at high shear rate, mainly dependent on plasma hyper®brinogenaemia, may increase the risk for blood¯ow disturbances in large arteries, also modifying circulation and thixotropy in microvascular regions. 25, 26 Moreover the alteration of high shear rate blood viscosity may re¯ect a disorder of the normal erythrocyte deformability that was found to be very reduced in central obesity. 10, 12 The coexistence of plasma hyperviscosity, reduced red cell deformability and increased erythrocyte aggregation (derived from the high values of blood viscosity at 1/200 ratio) 38 is more relevant in patients with central obesity, characterizing a deep rheological derangement in these subjects and an incipient risk of macrovascular and microvascular complications. The demonstration of increased plasma ®bronectin concentrations in our patients with central obesity may already identify early endothelial functional damage, since ®bronectin is a glycoprotein mainly derived from endothelial cells, during physiological and pathological conditions. 35, 41 Haemorheological alterations found in central obesity can therefore represent an important sign of blood¯ow dysregulation inducing a potential risk to develop widespread vascular disease.
In fact, in agreement with previous data, 17±19,23±25,32 alterations of the transcapillary permeability to plasma proteins in obese patients were reported in the present study and were related to the increase of urinary excretion rate of low and high molecular weight serum proteins. In this context, it is interesting to Concerning the origin of proteinuria, a total glomerular component was suggested in patients with central obesity, since tubular function, mainly expressed by the measurement of urinary a1-microglobulin concentrations, 42, 43 was similar in healthy subjects and in obese patients with different body fat topography.
Haemodynamic, metabolic and haemorheologic components are likely to be connected with the development of proteinuria in obese patients. Among the haemodynamic factors, glomerular hyper®ltration and sustained increase of glomerular hydraulic pressure have been considered to play a key role. 17, 18, 44 As seen in other studies, increased glomerular ®ltration rate (GFR) was found in patients with central obesity, and hyper®ltration was linked to the haemodynamic mechanism leading to proeinuria. 17, 18, 22, 44 Several metabolic factors may be related to increased GFR in these patients, including blood lipid abnormalities, increased blood glucose response and reduced glucagon suppression after oral glucose load. In fact blood glucose and glucagon have been clearly identi®ed as positive factors in the regulation of renal haemodynamic function. 45 The metabolic components may therefore sustain the haemodynamic mechanism of proteinuria in central obesity.
Another original point concerns the linkage between haemorheologic changes and the urinary excretion of proteins observed in our study. The pathologic increase of blood viscosity at low shear rate, found in centrally obese patients, signi®cantly correlates with the urinary excretion of proteins and in particular with those having high molecular weight (that is IgG and IgA). As originally suggested by previous studies, 33±36 proteinuria of centrally obese patients may therefore be haemorheologically linked, so suggesting an important haemodynamic action of blood hyperviscosity probably dependent on the enhancement of intraglomerular pressure. The suggested haemorheologic mechanism of proteinuria in patients with central obesity would seem to be independent of all the other clinical and metabolic variables and in particular of blood pressure, blood glucose and serum lipid concentrations. However, in spite of the lack of correlation between GFR and blood rheology, the increase of GFR might be a response to hyperviscosity so contributing, together with rheological changes, to increase the amount of ®ltered proteins.
Conclusions
Haemorheological factors might determine leakage and widespread increased capillary permeability in obesity. It is relevant to observe that blood rheology disorders and pathological proteinuria were especially found in patients with obesity of central type before any clinical evidence of arterial hypertension and angiopathic complications, so indicating two main components of risk in the absence of active vascular disease. Notwithstanding the improvement of proteinuria and blood rheology during very low calorie diet in obese diabetic and non diabetic subjects, 15, 16, 46 a more speci®c treatment with haemorheologic drugs and ACE-inhibitors may be suggested in order to reduce the prevalence of morbid vascular complications.
